Stocks and Investing Stocks and Investing
Tue, August 13, 2024

Anupam Rama Maintained (TVTX) at Buy with Increased Target to $20 on, Aug 13th, 2024


Published on 2024-10-28 13:36:20 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Increased Target from $19 to $20 on, Aug 13th, 2024.

Anupam has made no other calls on TVTX in the last 4 months.



There are 5 other peers that have a rating on TVTX. Out of the 5 peers that are also analyzing TVTX, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Allison Bratzel of "Piper Sandler" Maintained at Hold with Increased Target to $12 on, Friday, August 2nd, 2024


These are the ratings of the 4 analyists that currently disagree with Anupam


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $20 on, Monday, August 5th, 2024
  • Carter Gould of "Barclays" Maintained at Buy with Increased Target to $14 on, Friday, August 2nd, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $16 on, Friday, August 2nd, 2024
  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 7th, 2024
Contributing Sources